P1075: Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric studyECCO'24Year: 2024
Authors: Monin, L.(1)*;Reenaers, C.(1);Grandfils, S.(2);Latour, P.(1);Van Kemseke, C.(1);Kropp, S.(1);Louis, E.(1);Vieujean, S.(1);
(1)University Hospital CHU of Liège, Hepato-Gastroenterology and Digestive Oncology, Liège, Belgium;(2)University Hospital CHU of Liège, Gynecology and Obstetrics, Liège, Belgium;
P1077: Patients’ and Gastroenterologists’ Preferences on Outcomes and Medication Attributes for Ulcerative colitisECCO'24Year: 2024
Authors: Katsoula, A.(1,2)*;Paschos, P.(2,3);Giouleme, O.(1);Toumbalidou, M.(2);Mainou, M.(2,4);Malandris, K.(2);Tsapas, A.(2,4,5);
(1)Hippokration Hospital, Gastroenterology Division-Second Propaedeutic Department of Internal Medicine - Medical School - Aristotle University of Thessaloniki, Thessaloniki, Greece;(2)Clinical Research and Evidence-Based Medicine Unit, Second Medical Department- Aristotle University of Thessaloniki, Thessaloniki, Greece;(3)First Department of Internal Medicine, “Papageorgiou” Hospital, Thessaloniki, Greece;(4)Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;(5)Harris Manchester College, University of Oxford, Oxford, United Kingdom;This study was funded by a research grant 2020EOMIFNEp5 from the Hellenic Group for the Study of IBD (EOMIFNE)
P1078: The influence of different 5-aminosalicylic acid preparations on mercaptopurine metabolismECCO'24Year: 2024
Authors: AnjieMD, S.(1)*;Hettinga, J.(1);Volkers, A.G.(1);van Gennep, S.(1);Clasquin, E.(1);Duijvestein, M.(2);van Bodegraven, A.A.(3);van der Zanden, E.P.(4);Jansen, J.M.(5);van Asseldonk, D.P.(6);West, R.L.(7);D@E@Haens, G.R.A.M.(1);Löwenberg, M.(1);de Boer, N.K.(8);
(1)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Radboudumc, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(3)Zuyderland, Department of Gastroenterology and Hepatology, Sittard-Geleen, The Netherlands;(4)Ziekenhuis Amstelland, Department of Gastroenterology and Hepatology, Amstelveen, The Netherlands;(5)OLVG, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)Noordwest Ziekenhuisgroep, Department of Gastroenterology and Hepatology, Alkmaar, The Netherlands;(7)Franciscus Gasthuis, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(8)Amsterdam Gastroenterology Endocrinology Metabolism Research Institute- Amsterdam University Medical Centre- Vrije Universiteit Amsterdam- Amsterdam- The Netherlands, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;
P1079: Mindfulness-based cognitive therapy to reduce psychological distress in patients with Inflammatory Bowel Disease: first results of a multicentre randomised controlled trial (MindIBD).ECCO'24Year: 2024
Authors: Ter Avest, M.(1,2,3)*;Speckens, A.(1,3);Dijkstra, G.(4);Dresler, M.(3);Bosman, S.(1,3);Horjus, C.(5);Römkens, T.(2);Witteman, E.(6);Van Dop, W.(7);Nissen, L.(2);Huijbers, M.(1);
(1)Radboud University Medical Centre, Department of Psychiatry- Centre for Mindfulness, Nijmegen, The Netherlands;(2)Jeroen Bosch Hospital, Department of Gastroenterology and Hepatology, @E@s-Hertogenbosch, The Netherlands;(3)Radboud University Medical Centre, Donders Institute for Brain- Cognition and Behaviour, Nijmegen, The Netherlands;(4)University Medical Centre Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(5)Rijnstate Hospital, Department of Gastroenterology and Hepatology, Arnhem, The Netherlands;(6)Canisius Wilhelmina Hospital, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(7)Radboud University Medical Centre, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;
P107: Comparing the Colonic Tissue Proteome of Active and Inactive Ulcerative ColitisECCO'24Year: 2024
Authors: Penner, R.(1)*;de Almeida, L.(2);Rosentreter, R.(3);Hirota, S.(4);Dufour, A.(2);Lu, C.(1);
(1)University of Calgary, Division of Gastroenterology and Hepatology- Department of Medicine- University of Calgary, Calgary, Canada;(2)University of Calgary, Department of Biochemistry and Molecular Biology- University of Calgary- Alberta, Calgary, Canada;(3)University of Calgary, Division of Gastroenterology and Hepatology- Department of Medicine- University of Calgary1, Calagary, Canada;(4)University of Calgary, Department of Physiology & Pharmacology- University of Calgary- Alberta, Calgary, Canada;
P1080: Real-world Study on Early Predictors of Infliximab Treatment Efficacy in Crohn@E@s diseaseECCO'24Year: 2024
Authors: Lv, C.(1)*;Chen, Y.(2);Yan, F.(3);Pi, S.(2);Liu, Y.(2);Chen, R.(1);Tang, W.(1);Zhang, H.(3);
(1)The Second Affiliated Hospital of Soochow University, Gastroenterology, Suzhou, China;(2)Suzhou Medical College of Soochow University, Pathology- School of Biology and Basic Medical Sciences, Suzhou, China;(3)The First Affiliated Hospital of Nanjing Medical University, Gastroenterology, Nanjing, China;
P1081: Pharmacokinetics and immunogenicity of the ustekinumab biosimilar candidate ABP 654 in patients with moderate-to-severe plaque psoriasisECCO'24Year: 2024
Authors: Chow, V.(1)*;Mytych, D.T.(1);Blauvelt, A.(2);Papp, K.(3);Barragan, C.(1);Yamauchi, P.(4);Crowley, J.(5);Franklin, J.(1);
(1)Amgen Inc, Biosimilars Business Unit, Thousand Oaks, United States;(2)Oregon Medical Research Center, Oregon Medical Research Center, Portland, United States;(3)Alliance Clinical Trials Probity Medical Research, Alliance Clinical Trials Probity Medical Research, Waterloo, Canada;(4)Dermatology Institute & Skin Care Center- Inc., Clinical Science Institute, Santa Monica, United States;(5)Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, United States;
P1082: A comparative analysis of persistence of advanced therapies among patients with Inflammatory Bowel Disease in TaiwanECCO'24Year: 2024
Authors: Chiu, H.Y.(1)*;Le, P.H.(2);Kuo, C.J.(2);Lai, M.W.(3);Wu, R.C.(4);Chen, C.M.(5);Chiu, C.T.(2);Chiu, C.H.(6);Su, M.(7);Pan, Y.B.(8);
(1)Chang Gung University, School of Medicine, Taoyuan City, Taiwan;(2)Chang Gung Memorial Hospital- Linkou Branch, Department of Gastroenterology and Hepatology, Taoyuan City, Taiwan;(3)Chang Gung Memorial Hospital- Linkou Branch, Division of Pediatric Gastroenterology- Department of Pediatrics, Taoyuan City, Taiwan;(4)Chang Gung Memorial Hospital- Linkou Branch, Department of Anatomic Pathology, Taoyuan City, Taiwan;(5)Chang Gung Memorial Hospital- Linkou Branch, Department of Medical Imaging and Interventions, Taoyuan City, Taiwan;(6)Chang Gung Memorial Hospital- Linkou Branch, Division of Pediatric Infectious Diseases- Department of Pediatrics, Taoyuan City, Taiwan;(7)New Taipei City Municipal Tucheng Hospital, Department of Gastroenterology and Hepatology, New Taipei City, Taiwan;(8)Biostatistical Section- Clinical Trial Center, Chang Gung Memorial Hospital- Linkou Branch, Taoyuan City, Taiwan;
P1083: Patient preferences for Inflammatory Bowel Disease treatments: an international survey using a discrete choice experiment in partnership with EFCCAECCO'24Year: 2024
Authors: Schoefs, E.(1);Janssens, R.(1);Gutiérrez-Vargas, Á.A.(2);Ferrante, M.(3,4);Sabino, J.(3,4);Verstockt, B.(3,4);Avedano, L.(5);De Rocchis, M.S.(5)*;Sajak-Szczerba, M.(5);Saldaña, R.(5);Straetemans, N.(6,7);Vandebroek, M.(2);Vermeire, S.(3,4);Huys, I.(1);
(1)KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium;(2)KU Leuven, Faculty of Economics and Business, Leuven, Belgium;(3)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(4)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(5)EFCCA, European Federation of Crohn’s & Ulcerative Colitis Associations, Brussels, Belgium;(6)az Vesalius, Department of Gastroenterology, Tongeren, Belgium;(7)BINAStoria, Belgian IBD Nurses and Study Coordinators Association, Brussels, Belgium;
P1084: Persistence and efficacy of Ustekinumab in Crohn@E@s disease after antiTNF failure. May the response of the second biologic therapy be better than the first one?ECCO'24Year: 2024
Authors: Latrás Cortés, I.(1)*;Saéz Hortelano, J.C.(2);Suárez Álvarez, P.(1);García Prada, M.(1);Cano Sanz, N.(1);Ortega Valin, L.(2);Sierra Ausín, M.(1);
(1)University Hospital of León, Gastroenterology-IBD Unit, León, Spain;(2)University Hospital of León, Pharmacology, León, Spain;
P1085: Machine learning to predict the efficacy of ustekinumab for ulcerative colitis.ECCO'24Year: 2024
Authors: Morikubo, H.(1)*;Tojima, R.(2);Maeda, T.(2);Matsuoka, K.(3);Matsuura, M.(1);Miyoshi, J.(1);Tamura, S.(2);Hisamatsu, T.(1);
(1)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Mitaka, Japan;(2)Gifu University Faculty of Engineering, Department of Electrical- Electronic and Computer Engineering, Gifu, Japan;(3)Toho University Sakura Medical Center, Division of Gastroenterology and Hepatology- Department of Internal Medicine, Chiba, Japan;
P1086: Re-administration of infliximab in patients with extremely refractory perianal Crohn’s diseaseECCO'24Year: 2024
Authors: Mousourakis, K.(1)*;Veretanos, C.(1);Arvanitis, K.(1);Georgiadi, T.(1);Nousias, G.(1);Kozompoli, D.(1);Mylonas, I.(1);Paparizou, A.(1);Karaouzas, L.(1);Kalogiros, G.(1);Patsi, M.(1);Provi, D.(1);Christidou, A.(1);Mela, M.(1);Archavlis, E.(1);Papastergiou, V.(1);Varytimiadis, K.(1);Katopodi, K.(1);Chatzievangelinou, C.(1);Viazis, N.(1);
(1)Evangelismos Hospital, Gastroenterology Department, Athens, Greece;
P1087: A retrospective study on the GLIM criteria for assessing malnutrition in patients with Crohn@E@s Disease and its correlation with clinical outcomes.ECCO'24Year: 2024
Authors: Song, X.(1)*;Zhou, X.(2);Yang, J.(2);Guo, H.(1);
(1)Chongqing General Hospital, Gastroenterology, Chongqing, China;(2)The Third Affiliated Hospital of Chongqing Medical University, Research Center for Metabolic and Cardiovascular Diseases-Department of Clinical Nutrition., Chongqing, China;
P1088: Real-world data on the treatment with Upadacitinib in a biological-experienced Crohn@E@s disease cohortECCO'24Year: 2024
Authors: Kubesch, A.(1)*;Lande, R.(1);Farrag, K.(1);Jungheim, F.(1);Dienethal, A.(1);Sprinzl, K.(1);Zeuzem, S.(1);Blumenstein, I.(1);
(1)Goethe University Frankfurt- University Hospital- Medical Clinic 1, Department of Gastroenterology and Hepatology, Frankfurt, Germany;
P1089: Disease characteristics at time of diagnosis of adult onset inflammatory bowel disease and the risk of venous thromboembolism in the modern era – A Swedish nationwide cohort study 2007-2021ECCO'24Year: 2024
Authors: Bröms, G.(1)*;Forss, A.(1);Eriksson, J.(1);Linder, M.(1);Eriksson, C.(2);Askling, J.(1);Halfvarson, J.(2);Ludvigsson, J.F.(3);Olen, O.(1);
(1)Karolinska institutet, Medicine Solna, Stockholm, Sweden;(2)Örebro University, Gastroenterology, Örebro, Sweden;(3)Karolinska institutet, Medical Epidemiology and Biostatistics, Stockholm, Sweden;
P108: Response to vedolizumab in ulcerative colitis is associated with reduced neutrophil extracellular traps formation and IL-1β production: insights from NEUTROVED study.ECCO'24Year: 2024
Authors: Gavriilidis, E.(1);Divolis, G.(2);Kafalis, N.(3)*;Kogias, D.(1);Natsi, A.M.(4);Antoniadou, C.(1);Papadimitriou, E.(1);Tsironidou, V.(4);Giatromanolaki, A.(5);Ritis, K.(1);Kouklakis, G.(3);Skendros, P.(1);
(1)Democritus University of Thrace, First Department of Internal Medicine- University Hospital of Alexandroupolis, Alexandroupolis, Greece;(2)Biomedical Research Foundation Academy of Athens, Center for Clinical- Experimental Surgery and Translational Research, Athens, Greece;(3)Democritus University of Thrace, Gastroenterology-Hepatology Unit- University Hospital of Alexandroupolis, Alexandroupolis, Greece;(4)Democritus University of Thrace, Laboratory of Molecular Hematology, Alexandroupolis, Greece;(5)Democritus University of Thrace, Department of Pathology- University Hospital of Alexandroupolis, Alexandroupolis, Greece;
P1090: Exposure to an inflammatory prenatal environment and the risk of Inflammatory Bowel Disease in the offspring: a population-based cohort studyECCO'24Year: 2024
Authors: Bonfils, L.(1)*;Poulsen, G.(1);Agrawal, M.(1,2);Julsgaard, M.(1,3);Torres, J.(2,4,5);Jess, T.(1,6);Allin, K.(1,6);
(1)Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT, Department of Clinical Medicine- Aalborg University, Copenhagen, Denmark;(2)Icahn School of Medicine at Mount Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York City, United States;(3)Aarhus University Hospital, Department of Hepatology and Gastroenterology- Aarhus University Hospital, Aarhus, Denmark;(4)Hospital da Luz, Division of Gastroenterology, Lisboa, Portugal;(5)Hospital Beatriz Ângelo, Division of Gastroenterology, Loures, Portugal;(6)Aalborg University Hospital, Department of Gastroenterology & Hepatology, Aalborg, Denmark;
P1091: Cross-domain dynamics of the fungal-bacterial microbiome in patients with ulcerative colitisECCO'24Year: 2024
Authors: Jangi, S.(1)*;Hsia, K.(2);zhao, N.(3);michaud, D.(3);
(1)Tufts Medical Center, Gastroenterology, Cambridge, United States;(2)Tufts Medical Center, Medicine, Boston, United States;(3)Tufts Medical Center, Public Health, Boston, United States;
P1093: Early life exposure to agriculture and biodiversity influences Crohn’s disease risk in a population-based cohort studyECCO'24Year: 2024
Authors: Agrawal, M.(1,2)*;Vinkel Hansen, A.(2);Colombel, J.F.(1);Jess, T.(2,3);Allin, K.(2,3);
(1)Icahn School of Medicine at Mount Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States;(2)Aalborg University, Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Department of Clinical Medicine, Copenhagen, Denmark;(3)Aalborg University Hospital, Department of Gastroenterology & Hepatology, Aalborg, Denmark;
P1094: Rectal cancer in patients with inflammatory bowel disease - a nationwide cohort studyECCO'24Year: 2024
Authors: Lundqvist, E.(1)*;Westerberg, K.(2);Dietrich, C.(3);Martling, A.(4);Myrelid, P.(5);Nordenvall, C.(4);
(1)PhD-student- MD, Department of Biomedical and Clinical Sciences- Linköping University, Linköping, Sweden;(2)Karolinska Institute, Department of Molecular Medicine and Surgery-, Stockholm, Sweden;(3)Karolinska Institute, Division of Clinical Epidemiology- Department of Medicine, Stockholm, Sweden;(4)Karolinska Institute, Department of Molecular Medicine and Surgery, Stockholm, Sweden;(5)Linköping University, Department of Biomedical and Clinical Sciences, Stockholm, Sweden;
